Mark T. Mcloughlin serves as Executive at CYTOMEDIX INC, where they oversee executive responsibilities. Since joining the company, Mark T. Mcloughlin has executed 4 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 21, 2017 involved selling 5,945 shares valued at $197.7K.
Mark T. Mcloughlin currently holds 5,945 shares of CYTOMEDIX INC (GTF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark T. Mcloughlin has been a net buyer of GTF stock. They have purchased $10.0K and sold $0 worth of shares.
Mark T. Mcloughlin's most recent insider trade was on Nov 21, 2017, when they sold 5,945 shares at $33.25 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 29, 2012 | CMXI | $0 | Exercise | 6,667 | $N/A | Discretionary |
| Sep 5, 2008 | GTF | $10.0K | Purchase | 13,334 | $0.75 | Discretionary |